[{"NetIncomeLoss_1_Q3_USD":-92439000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":21539000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":107900000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":35445000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":36.66,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-134000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-336926000.0,"Depreciation_3_Q3_USD":6600000.0,"Depreciation_1_Q3_USD":2300000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":494589000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":41.35,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1468758.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q3_USD":1000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":154000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":62442000.0,"AssetsCurrent_0_Q3_USD":1390939000.0,"FairValueNetAssetLiability_0_Q3_USD":16000000.0,"TreasuryStockShares_0_Q3_shares":195316.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":8842224.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":8842224.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":12659000.0,"TreasuryStockValue_0_Q3_USD":63000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":100000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":100000.0,"CommonStockSharesIssued_0_Q3_shares":70799178.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":324573000.0,"Assets_0_Q3_USD":1485018000.0,"ShareBasedCompensation_3_Q3_USD":47088000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":38454000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":582225000.0,"OtherNoncashExpense_3_Q3_USD":979000.0,"CommonStockParOrStatedValuePerShare_0_Q3_CHF":0.03,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":28.68,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-144000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":184581000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":71008000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":36.66,"EarningsPerShareBasic_1_Q3_USD":-1.32,"EarningsPerShareBasic_3_Q3_USD":-3.77,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":70143481.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":64159224.0,"AccountsReceivableNetCurrent_0_Q3_USD":110000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":956000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":200000.0,"CommonStockValue_0_Q3_USD":2157000.0,"OtherNonoperatingIncome_3_Q3_USD":5804000.0,"OtherNonoperatingIncome_1_Q3_USD":160000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q3_USD":0.0,"MarketableSecuritiesCurrent_0_Q3_USD":324573000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":17394000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":307053.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":-0.004,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":-0.002,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":603525000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":509000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-241967000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-92552000.0,"OtherAssetsNoncurrent_0_Q3_USD":662000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1041417000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":38570000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1807878000.0,"Liabilities_0_Q3_USD":141717000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":21300000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-144000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":6618000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-350000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-19273000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":349000.0,"RestrictedCashNoncurrent_0_Q3_USD":16845000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":325316000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":7932906.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":18623000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-113000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":11000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-240870000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-92239000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":17240000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":3000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":31000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-157154000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":64159224.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":70143481.0,"EarningsPerShareDiluted_1_Q3_USD":-1.32,"LiabilitiesCurrent_0_Q3_USD":84149000.0,"NonoperatingIncomeExpense_3_Q3_USD":5804000.0,"NonoperatingIncomeExpense_1_Q3_USD":160000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":24839000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":5000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":6784000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":38000.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":915704000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":1058262000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":1011236.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":194000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":2863000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":37924000.0,"NetIncomeLoss_3_Q3_USD":-241826000.0,"AccountsPayableCurrent_0_Q3_USD":19020000.0,"CommonStockSharesAuthorized_0_Q3_shares":115172786.0,"EarningsPerShareDiluted_3_Q3_USD":-3.77,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":11000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":148000.0,"OperatingIncomeLoss_3_Q3_USD":-246674000.0,"OperatingIncomeLoss_1_Q3_USD":-92399000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":610000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":56.19,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":22.34,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1485018000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":14327000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":47088000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":17240000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":105500000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":56547000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":10640000.0,"OperatingExpenses_3_Q3_USD":247023000.0,"CommonStockSharesOutstanding_0_Q3_shares":70603862.0,"OperatingExpenses_1_Q3_USD":92547000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":7222000.0,"OtherLiabilitiesCurrent_0_Q3_USD":12086000.0,"StockholdersEquity_0_Q3_USD":1343301000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":11776000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":12119000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":324716000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-6037000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":7932906.0,"TaxesPayableCurrent_0_Q3_USD":6348000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":3741338.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-466537000.0,"PropertyPlantAndEquipmentFairValueDisclosure_0_Q3_USD":9340000.0,"MarketableSecurities_0_Q3_USD":125700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":109450000.0,"ProfitLoss_3_Q3_USD":-241826000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1762000.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201028"}]